The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Nitazenes—heralding a second wave for the UK drug-related death crisis?
Open accessAbstract
The UK is in the midst of a drug-related crisis.1Holland A Stevens A Harris M et al.Analysis of the UK Government's 10-year drugs strategy—a resource for practitioners and policymakers.J Public Health. 2023; 45: e215-e224Crossref Scopus (5) Google Scholar Likely contributory factors include: disinvestment in drug treatment, harm reduction, and public services; changing patterns of socioeconomic deprivation; increasing poly-drug use; and an ageing cohort of people who use heroin.1Holland A Stevens A Harris M et al.Analysis of the UK Government's 10-year drugs strategy—a resource for practitioners and policymakers.J Public Health. 2023; 45: e215-e224Crossref Scopus (5) Google Scholar The UK crisis has not reached the scale of that in the US where 106 699 overdose deaths were reported in 2021.2Centers for Disease Control and Prevention Drug overdose deaths.https://www.cdc.gov/drugoverdose/deaths/index.htmlDate: Aug 22, 2023Date accessed: November 22, 2023Google Scholar The latest wave of the crisis in the US has been driven primarily by fentanyl and other synthetic opioids, which were implicated in 88% of these deaths.2Centers for Disease Control and Prevention Drug overdose deaths.https://www.cdc.gov/drugoverdose/deaths/index.htmlDate: Aug 22, 2023Date accessed: November 22, 2023Google Scholar Highly potent synthetic opioids have not played such a prominent role in rising deaths among people who use drugs in the UK. Global drug markets are, however, rapidly evolving. Of particular concern is the emergence of nitazenes: a class of synthetic opioids developed by the pharmaceutical industry in the 1950s but never approved as medicines.3Ujváry I Christie R Evans-Brown M et al.DARK classics in chemical neuroscience: etonitazene and related benzimidazoles.ACS Chem Neurosci. 2021; 12: 1072-1092Crossref PubMed Scopus (39) Google Scholar Like other opioids, nitazenes can cause fatal respiratory depression, and some are hundreds of times more potent than heroin (table).3Ujváry I Christie R Evans-Brown M et al.DARK classics in chemical neuroscience: etonitazene and related benzimidazoles.ACS Chem Neurosci. 2021; 12: 1072-1092Crossref PubMed Scopus (39) Google Scholar In the UK, nitazenes have been detected in substances sold as other opioids, benzodiazepines, and cannabis products.4WEDINOS Annual Report April 2022–March 2023.https://www.wedinos.org/resources/downloads/Annual-Report-22-23-English.pdfDate: 2023Date accessed: July 28, 2023Google Scholar This means many consumers are using nitazenes inadvertently, unaware of the risks they face.TableThe relative potency of fentanyl and selected nitazenes in comparison to heroin2Centers for Disease Control and Prevention Drug overdose deaths.https://www.cdc.gov/drugoverdose/deaths/index.htmlDate: Aug 22, 2023Date accessed: November 22, 2023Google Scholar, 3Ujváry I Christie R Evans-Brown M et al.DARK classics in chemical neuroscience: etonitazene and related benzimidazoles.ACS Chem Neurosci. 2021; 12: 1072-1092Crossref PubMed Scopus (39) Google ScholarRelative potency to heroinHeroin1Fentanyl50Metonitazene50Protonitazene100Isotonitazene250Etonitazene500 Open table in a new tab The UK National Crime Agency reported 54 deaths in the last six months where nitazenes were detected in post-mortem toxicology.5Homer A Johal N Street drugs stronger than heroin linked to 54 deaths in UK.https://www.bbc.com/news/uk-67589364Date: Dec 11, 2023Date accessed: December 18, 2023Google Scholar This is likely the tip of the iceberg, as many tests are still in process and emerging drugs are not routinely tested for. Other European countries, particularly the Baltic states, have also reported increasing numbers of deaths related to nitazenes.6European Monitoring Centre for Drugs and Drug Addiction Drug-induced deaths – the current situation in Europe (European Drug Report 2023).https://www.emcdda.europa.eu/sites/default/files/pdf/31087_en.pdf?82341Date: June 16, 2023Date accessed: December 18, 2023Google Scholar Potent synthetic drugs offer clear benefits for producers. They can be manufactured rapidly and inexpensively, without relying on illicit crops susceptible to eradication. Most of the heroin in Europe originates in Afghanistan. The Taliban recently prohibited opium cultivation, leading to a dramatic reduction in production.7ALCIS Massive reduction of opium production in Afghanistan.https://www.alcis.org/poppyDate: June 6, 2023Date accessed: July 28, 2023Google Scholar The resultant gap in the market could lead to nitazenes becoming increasingly prominent across Europe. Enforcement and stricter scheduling cannot be expected to solve a problem that has developed in the context of, and might have been exacerbated by, interdiction and prohibition. Without concerted action, nitazenes could devastate communities of people who use a range of drugs, including those who use drugs infrequently or source benzodiazepines and opioid painkillers from the internet. Drugs services must adapt to improve
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“| Etonitazene | 500 |”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Detection of nitazene analogs in wastewater samples in multiple countries demonstrate the global distribution of nitazenes [28].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The UK National Crime Agency reported 54 nitazene-related deaths within six months, a scenario likely to be an underestimation [19].”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“We did not detect any nitazenes in wastewater samples collected from the United Kingdom, despite growing reports of nitazenes in this region over the past year [32].”
From Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries (2025) · cites this paper as [32]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“| Isotonitazene | 250 |”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [28]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug checking services for people who use drugs: a systematic review
Maghsoudi, N., Tanguay, J., Scarfone, K., Rammohan, I., Ziegler, C., Werb, D., & Scheim, A. I. (2022) · Addiction · doi:10.1111/add.15734 · Cited by 261
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141
Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers
Holland, A., Stevens, A., Harris, M., Lewer, D., Sumnall, H. R., Stewart, D. E., Gilvarry, E. A., Wiseman, A., Howkins, J., McManus, J., et al. (2022) · Journal of Public Health · doi:10.1093/pubmed/fdac114 · Cited by 39
Self-citationFischer, B., & Robinson, T. (2023) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.23-00195 · Cited by 15
Overdose prevention centres in the UK
Holland, A., Harris, M., Hickman, M., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(22)00038-x · Cited by 13
Self-citation
Cited by
De Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
Nitazenes represent a growing threat to public health in Europe
Giraudon, I., Abel-Ollo, K., Vanaga-Arāja, D., Heudtlass, P., & Griffiths, P. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00024-0 · Cited by 40
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Vandeputte, M. M., Glatfelter, G. C., Walther, D., Layle, N. K., St. Germaine, D. M., Ujváry, I., Iula, D. M., Baumann, M. H., & Stove, C. P. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107503 · Cited by 35
The public health risks of counterfeit pills
Friedman, J., & Ciccarone, D. (2025) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00273-1 · Cited by 32
Metadata
- Authors
- Holland, A., Copeland, C. S., Shorter, G. W., Connolly, D. J., Wiseman, A., Mooney, J., Fenton, K., & Harris, M.
- Affiliations
- University of Bristol (GB)
- King's College London (GB)
- Queen's University Belfast (GB)
- Faculty of Public Health (GB)
- National Health Service (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Holland, Adam
- ORCID
- Venue
- The Lancet Public Health
- Publisher
- Elsevier BV
- Published
- 2024-02
- Volume
- 9
- Issue
- 2
- Pages
- e71-e72
- ISSN
- 2468-2667 (ISSN-L)
- PMC
- PMC7617954
- OpenAlex
- W4390811970
- Cited by
- 86
- References
- 5
- Citations by year
- 2026: 22 · 2025: 37 · 2024: 27
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Public Health (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion, cc-by)
- Research Portal (Queen's University Belfast) (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion, cc-by)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nitazenes, drug-related deaths, synthetic opioids, etonitazene, benzimidazole, opioid overdose, drug policy, harm reduction, polydrug use, heroin users, drug purity testing
- MeSH terms
- Benzimidazoles, United Kingdom, Humans, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nitazenes—heralding a second wave for the UK drug-related death crisis? https://app.cochat.ai/papers/10.1016/s2468-2667(24)00001-x
- The paper
- Holland, A., Copeland, C. S., Shorter, G. W., Connolly, D. J., Wiseman, A., Mooney, J., Fenton, K., & Harris, M. (2024). Nitazenes—heralding a second wave for the UK drug-related death crisis? The Lancet Public Health. https://doi.org/10.1016/s2468-2667(24)00001-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.